Skip to main content

Table 1 Characteristics of the studies included in the systematic review

From: Oxygenation strategies during flexible bronchoscopy: a review of the literature

 

Year

Patients enrolled

FOB performed

Study type

Clinical status

Setting

RS before FOB

RS during FOB

FOB purpose

Analgosedation strategy

Main outcomes

Antonelli M., et al. [1]

1996

8

8

Interventional

Acute

ICU

COT

NPPV

Diagnostic

Lidocaine

O2 saturation, PaO2/FiO2, PaCO2,

RR, HR, intubation, mortality

Jones A.M., et al. [9]

2000

1074

2261

Observational

Chronic

Ward

None

COT

Diagnostic

Midazolam, lignocaine

O2 saturation

Onakpoya U.U., et al. [10]

2012

61

67

Observational

Chronic

Ward

None

COT

Diagnostic

Diazepam, lignocaine

O2 saturation

Golpe R., Mateos A. [11]

2002

44

44

Observational

ND

ND

None

COT

ND

Lignocaine

O2 saturation

Alijanpour E., et al. [12]

2010

146

146

Observational

ND

ND

None

COT

ND

Lidocaine

O2 saturation

Cracco C., et al. [13]

2013

169

181

Observational

Acute

ICU

COT, NPPV

COT, NPPV

Diagnostic, therapeutic

ND

Intubation, increased ventilatory support

Ghio A.J., et al. [14]

2007

12

12

Prospective randomized

Healthy volunteers

Outpatients

COT or none

COT or none

Research

Lidocaine

O2 saturation

McCain T.W., et al. [15]

2001

97

97

Prospective randomized

Chronic

ND

COT

COT

Diagnostic

Meperidine or fentanyl, midazolam

O2 saturation,

O2 flow rate

Miyagi K., et al. [16]

2014

5

5

Observational

Acute

ICU

COT

HFNC

Diagnostic

ND

O2 saturation

La Combe B., et al. [17]

2016

30

30

Observational

Acute

ICU

COT

HFNC

Diagnostic

ND

O2 saturation, dyspnea, intubation, mortality

Longhini F., et al. [18]

2021

36

36

Prospective randomized

Chronic

Outpatients

None

COT or HFNC

Diagnostic

Lidocaine

O2 saturation, PaO2, ΔEELI, DD, TF

Chung S.M., et al. [19]

2018

10

10

Observational

Acute, chronic

Ward

COT

HFNC

Diagnostic, therapeutic

Midazolam, propofol, lidocaine

O2 saturation

Service J.A., et al. [20]

2018

182

182

Observational

Chronic

Outpatients

None

HFNC

Diagnostic

Remifentanil. propofol or midazolam

O2 saturation

Ben-Menachem E., et al. [21]

2020

76

76

Prospective randomized

Chronic

Ward

None

COT or HFNC

Diagnostic

ND

O2 saturation

Lucangelo U. et al. [22]

2012

45

45

Prospective randomized

Acute, chronic

Ward

None

COT or HFNC

Diagnostic

Midazolam, lidocaine

O2 saturation,

PaO2, PaO2/FiO2

Irfan M., et al. [23]

2021

40

40

Prospective randomized

Chronic

Ward

None

COT or HFNC

Diagnostic

ND

O2 saturation

Douglas N., et al. [24]

2018

60

60

Prospective randomized

Chronic

ND

None

COT or HFNC

Diagnostic

Midazolam, opioids and/or propofol, lidocaine

O2 saturation

Kim E.J., et al. [25]

2018

32

33

Observational

Acute

Ward

COT or HFNC

HFNC

Diagnostic

Midazolam, lidocaine

O2 saturation PaO2/FiO2

Maitre B., et al. [26]

2000

30

30

Prospective randomized

Acute

Ward, ICU

COT

COT or CPAP

Diagnostic

Lidocaine

O2 saturation, PaO2, ventilatory assistance requirement

Antonelli M., et al. [27]

2002

26

26

Prospective randomized

Acute

ICU

COT

COT or NPPV

Diagnostic

Lidocaine

PaO2/FiO2, HR, MAP, intubation

Baumann H.J., et al. [28]

2011

40

40

Observational

Acute

ICU

NIV

NIV

Diagnostic, therapeutic

Midazolam, propofol, lidocaine

O2 saturation, PaO2/FiO2, PaCO2, intubation

Korkmaz Ekren P., et al. [29]

2016

28

28

Observational

Acute

ICU

NIV

NIV

Diagnostic, therapeutic

Midazolam, lidocaine

PaO2/FiO2, intubation

Chiner E., et al. [30]

2010

35

35

Observational

Acute

Ward, ICU

NIPPV

NIPPV

Diagnostic, therapeutic

Lidocaine

O2 saturation, RR, HR, intubation, mortality

Heunks L.M.A., et al. [31]

2010

12

12

Observational

Acute

ICU

COT

NPPV

Diagnostic

Xylocaine

O2 saturation, PaO2/FiO2, intubation

Antonelli M., et al. [32]

2003

4

4

Interventional

Acute

ICU

COT

NPPV

Diagnostic

Lidocaine

O2 saturation, PaO2/FiO2, PaCO2, RR, HR, MAP, intubation

Agarwal R., et al. [33]

2012

6

6

Observational

Acute

Ward

COT

NIV

Diagnostic, therapeutic

Lidocaine

O2 saturation, PaO2/FiO2, intubation

Chen X., et al. [34]

2020

29

29

Retrospective

Acute

Ward

COT

NIV, CMV

Therapeutic

Dezocine, midazolam, lidocaine

O2 saturation, PaO2, HR, SBP, type of procedures, success rate, procedure time

Da Conceiçao M., et al. [35]

2000

10

10

Prospective

Acute

ICU

None

NIPPV

Diagnostic

Lidocaine

O2 saturation, PaO2, PaCO2, intubation, mortality

Mohamed A.S., El-Sharawy D.E. [36]

2018

40

20

Prospective randomized

Acute

Ward

NIV

NIV

Therapeutic

Midazolam, lidocaine

O2 saturation

Scala R., et al. [37]

2010

30

30

Prospective

Acute

RICU, ICU

NPPV

NPPV, CMV

Diagnostic

Lidocaine

O2 saturation, PaO2/FiO2, PaCO2, pH

Simon M., et al. [38]

2014

40

40

Prospective randomized

Acute

ICU

COT

NIV or HFNC

Diagnostic, therapeutic

Propofol, lidocaine

O2 saturation, PaO2/FiO2, PaCO2, HR, MAP, procedure time, intubation, mortality

Saksitthichok B., et al. [39]

2019

51

51

Prospective randomized

Acute

Ward or RICU

NIV or HFNC

NIV or HFNC

Diagnostic

Fentanyl, lidocaine

O2 saturation, PaO2, PaCO2, pH, RR, HR, MAP, dyspnea

  1. ND not defined, FOB flexible fiberoptic bronchoscopy, RS respiratory support, ICU intensive care unit, RICU respiratory intermediate care unit, NIV noninvasive ventilation, COT conventional oxygen therapy, CPAP continuous positive airway pressure, HFNC high flow oxygen through nasal cannula, CMV conventional mechanical ventilation, PaO2 arterial partial pressure of oxygen, FiO2 fraction of inspired oxygen, PaCO2 arterial partial pressure of carbon dioxide, RR respiratory rate, HR heart rate, ΔEELI changes of end-expiratory lung impedance, DD diaphragm displacement, TF thickening fraction, MAP mean arterial pressure, SBP systolic blood pressure